Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Oral Maxillofac Surg ; 52(8): 875-884, 2023 Aug.
Article in English | MEDLINE | ID: mdl-36319581

ABSTRACT

Nasal obstruction is common in patients with a transverse maxillary deficiency. The aim of this study was to determine the variation in nasal airway resistance in adult patients with a transverse maxillary deficiency before and after surgically assisted rapid maxillary expansion (SARME) by computational fluid dynamics (CFD) using computed tomography scans, and to correlate this variation with maxillary linear measurements obtained by means of plaster models. The subjective symptoms of nasal obstruction were also analysed using a visual analogue scale (VAS) for nasal breathing and the Nasal Obstruction Symptom Evaluation (NOSE) scale. There was a median reduction of 21% in nasal airway resistance post SARME (P = 0.002). The NOSE scale score decreased (P < 0.001) and nasal breathing quality VAS scores increased in both nostrils (P < 0.001). Transverse measurements between the upper canines (C-C), premolars (PM-PM), and molars (M-M), and maxillary perimeter showed significant increases (P < 0.001), while the anteroposterior maxillary arch length showed a significant decrease (P = 0.016). An inverse proportional correlation was found between PM-PM and nasal airway resistance (r = -0.395; P = 0.034) and between M-M and nasal airway resistance (r = -0.383; P = 0.040). These results demonstrate that surgically expanding the posterior region of the maxilla results in decreased nasal airway resistance, decreased obstructive symptoms, and improved patient respiratory quality.


Subject(s)
Nasal Obstruction , Humans , Nasal Obstruction/diagnostic imaging , Nasal Obstruction/surgery , Maxilla/diagnostic imaging , Maxilla/surgery , Palatal Expansion Technique , Hydrodynamics , Symptom Assessment , Bicuspid
2.
J Immunoassay Immunochem ; 28(3): 279-88, 2007.
Article in English | MEDLINE | ID: mdl-17613673

ABSTRACT

LipL32 is the major lipoprotein in the membrane of pathogenic leptospira. In this work, we report on the production of monoclonal antibodies (MAbs) against recombinant LipL32 (rLipL32) and on the evaluation of their potential for use as reagents in diagnostic tests for leptospirosis. The MAbs were all of the IgG(2b) isotype and reacted specifically with native LipL32 in pathogenic serovars only. MAbs reacted in the same region of the rLipL32 molecule and their affinity constant was between 5x10(7) M(-1) and 6x10(6) M(-1). These results suggest that although the MAbs cannot be used together, they are well suited for diagnostic tests of leptospirosis based on LipL32 detection.


Subject(s)
Antibodies, Monoclonal/chemistry , Bacterial Outer Membrane Proteins/immunology , Leptospirosis/diagnosis , Lipoproteins/immunology , Antibodies, Monoclonal/biosynthesis , Antibodies, Monoclonal/isolation & purification , Antibody Specificity/immunology , Bacterial Outer Membrane Proteins/analysis , Diagnostic Tests, Routine , Humans , Immunoglobulin Isotypes/analysis , Immunologic Tests , Leptospirosis/immunology , Lipoproteins/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...